IT8441570A1 - Derivati dell'urochinasi ad azione farmacologica - Google Patents

Derivati dell'urochinasi ad azione farmacologica

Info

Publication number
IT8441570A1
IT8441570A1 IT1984A41570A IT4157084A IT8441570A1 IT 8441570 A1 IT8441570 A1 IT 8441570A1 IT 1984A41570 A IT1984A41570 A IT 1984A41570A IT 4157084 A IT4157084 A IT 4157084A IT 8441570 A1 IT8441570 A1 IT 8441570A1
Authority
IT
Italy
Prior art keywords
urokinase
derivatives
pharmacological action
pharmacological
action
Prior art date
Application number
IT1984A41570A
Other languages
English (en)
Other versions
IT1199522B (it
IT8441570A0 (it
Original Assignee
Vsesojuzny Kardiologichesky Nauceny Tsentr Akademii Meditsinskikh Nauk Sssr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsesojuzny Kardiologichesky Nauceny Tsentr Akademii Meditsinskikh Nauk Sssr filed Critical Vsesojuzny Kardiologichesky Nauceny Tsentr Akademii Meditsinskikh Nauk Sssr
Publication of IT8441570A0 publication Critical patent/IT8441570A0/it
Publication of IT8441570A1 publication Critical patent/IT8441570A1/it
Application granted granted Critical
Publication of IT1199522B publication Critical patent/IT1199522B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6462Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21073Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT41570/84A 1983-05-10 1984-05-09 Derivati dell'urochinasi ad azione farmacologica IT1199522B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU833590957A SU1128601A1 (ru) 1983-05-10 1983-05-10 Урокиназа,иммобилизированна на фибриногене

Publications (3)

Publication Number Publication Date
IT8441570A0 IT8441570A0 (it) 1984-05-09
IT8441570A1 true IT8441570A1 (it) 1985-11-09
IT1199522B IT1199522B (it) 1988-12-30

Family

ID=21063322

Family Applications (1)

Application Number Title Priority Date Filing Date
IT41570/84A IT1199522B (it) 1983-05-10 1984-05-09 Derivati dell'urochinasi ad azione farmacologica

Country Status (8)

Country Link
US (1) US4564596A (it)
JP (1) JPS60501239A (it)
DE (1) DE3490222T1 (it)
GB (1) GB2150576B (it)
IT (1) IT1199522B (it)
SE (1) SE442022B (it)
SU (1) SU1128601A1 (it)
WO (1) WO1984004536A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
CA1335361C (en) * 1989-05-24 1995-04-25 Andrei Z. Budzynski Thrombus-targeted complexes of plasminogen activator and fibrin fragments
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
CA2091544A1 (en) * 1992-03-26 1993-09-27 Shing F. Kwan Stabilization of functional proteins
US10127295B2 (en) * 2009-06-05 2018-11-13 Microsoft Technolofy Licensing, Llc Geographic co-location service for cloud computing
US8577892B2 (en) * 2009-06-05 2013-11-05 Microsoft Corporation Utilizing affinity groups to allocate data items and computing resources
RU2674032C1 (ru) * 2018-06-05 2018-12-04 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский национальный исследовательский университет информационных технологий, механики и оптики" (Университет ИТМО) Способ получения урокиназы, энтрапированной в коллоидный магнитный керамический нанокомпозитный материал

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3544427A (en) * 1968-04-18 1970-12-01 Century Lab Inc Method of production of urokinase
US4029767A (en) * 1971-09-24 1977-06-14 Choay S.A. Pharmaceutical compositions of stable urokinase-heparin complexes and methods for use thereof
DE2431342C3 (de) * 1973-07-27 1978-10-26 Behringwerke Ag, 3550 Marburg Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe
JPS6043116B2 (ja) * 1978-02-21 1985-09-26 株式会社ミドリ十字 ウロキナ−ゼ誘導体
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
GB2038337B (en) * 1978-12-21 1983-01-19 Green Cross Corp Process which comprises separation of urokinases having different molecular weights
SU1022988A1 (ru) * 1979-09-28 1983-06-15 Всесоюзный кардиологический научный центр АМН СССР Стабилизированна урокиназа,обладающа тромболитической активностью,и способ ее получени
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents

Also Published As

Publication number Publication date
SE442022B (sv) 1985-11-25
IT1199522B (it) 1988-12-30
SU1128601A1 (ru) 1985-07-15
SE8500093D0 (sv) 1985-01-09
US4564596A (en) 1986-01-14
GB8500165D0 (en) 1985-02-13
JPS60501239A (ja) 1985-08-08
DE3490222T1 (de) 1985-05-02
GB2150576A (en) 1985-07-03
SE8500093L (sv) 1985-01-09
IT8441570A0 (it) 1984-05-09
GB2150576B (en) 1987-02-25
JPH026513B2 (it) 1990-02-09
WO1984004536A1 (en) 1984-11-22

Similar Documents

Publication Publication Date Title
IT1139919B (it) Derivati dell'1-sulfo-2-ossoazetidina,loro produzione ed impiego
IT8519512A0 (it) Derivati naturali ad attivita'farmacologica
IT7849577A0 (it) Derivati spiroamminici ad attivita'farmacologica e relativo procedimento di produzione
IT1097314B (it) Derivati dell'imidazolo ad attivita' anticonvulsivante
IT8421273A1 (it) "derivati furanici con attivita' antiulcera"
IT8441570A1 (it) Derivati dell'urochinasi ad azione farmacologica
IT1167478B (it) Derivati dell'acido ursodesossicolico
IT8025285A0 (it) Derivati di prostagliandina e prostaciclina ad attivita'farmacologica.
IT1167479B (it) Derivati dell'acido chenodesossicolico
IT8449056A1 (it) Derivati dell' 1- 2 ditiolano loro preparazione e loro impiego come medicamenti
IT8248823A0 (it) Derivati dell'n-fenilpirazolo
IT1150726B (it) Derivati dell'acido ascorbico
IT7948802A0 (it) Derivati di n-alchenilmoranolina aventi attivita' farmacologica
IT1094287B (it) Derivati della 2-idrossimetil-pirazina aventi attivita' ipolipemizzante
IT1212902B (it) Derivati etendiamminici e guanidinici dotati di attivita' farmacologica
IT7950523A0 (it) Derivati carbamoil-piperazinici dotati di attivita' farmacologica
IT8220306A0 (it) Derivati dell'acido 2 o 4-tiazolidin-carbossilico 3-acilsostituiti ad azione fitoregolatrice e biostimolanti.
IT8422897A0 (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
IT8321456A0 (it) Derivati dell'acido fenil-etil-acetico ad attivita'antiinfiammatoria.
IT1171410B (it) Derivati dell'ergolina loro freparpzione e loro impiego come medicamenti
IT1184310B (it) Derivati dell'acido amminopropan-solfonico n-sostituiti
IT8519442A0 (it) Derivati di fenilpropargilammine
IT1222553B (it) Derivati dell' s-carbossimetilcisteina
IT1230114B (it) L'impiego in terapeutica dell'urochinasi insieme con la pro-urochinasi
IT1173454B (it) Derivati della pantetina ad attivita' antidislipemica